303 related articles for article (PubMed ID: 16700548)
21. Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands.
Medina-Carmona E; Palomino-Morales RJ; Fuchs JE; Padín-Gonzalez E; Mesa-Torres N; Salido E; Timson DJ; Pey AL
Sci Rep; 2016 Feb; 6():20331. PubMed ID: 26838129
[TBL] [Abstract][Full Text] [Related]
22. Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity.
Nolan KA; Zhao H; Faulder PF; Frenkel AD; Timson DJ; Siegel D; Ross D; Burke TR; Stratford IJ; Bryce RA
J Med Chem; 2007 Dec; 50(25):6316-25. PubMed ID: 17999461
[TBL] [Abstract][Full Text] [Related]
23. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
[TBL] [Abstract][Full Text] [Related]
24. Aerobic Cytotoxicity of Aromatic
Nemeikaitė-Čėnienė A; Šarlauskas J; Misevičienė L; Marozienė A; Jonušienė V; Lesanavičius M; Čėnas N
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228195
[TBL] [Abstract][Full Text] [Related]
25. Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells.
Buranrat B; Prawan A; Kukongviriyapan U; Kongpetch S; Kukongviriyapan V
World J Gastroenterol; 2010 May; 16(19):2362-70. PubMed ID: 20480521
[TBL] [Abstract][Full Text] [Related]
26. Dicoumarol impairs mitochondrial electron transport and pyrimidine biosynthesis in human myeloid leukemia HL-60 cells.
González-Aragón D; Ariza J; Villalba JM
Biochem Pharmacol; 2007 Feb; 73(3):427-39. PubMed ID: 17123468
[TBL] [Abstract][Full Text] [Related]
27. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
Colucci MA; Moody CJ; Couch GD
Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
[TBL] [Abstract][Full Text] [Related]
28. Human NAD(P)H:quinone oxidoreductase inhibition by flavonoids in living cells.
Lee YY; Westphal AH; de Haan LH; Aarts JM; Rietjens IM; van Berkel WJ
Free Radic Biol Med; 2005 Jul; 39(2):257-65. PubMed ID: 15964517
[TBL] [Abstract][Full Text] [Related]
29. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
[TBL] [Abstract][Full Text] [Related]
30. NAD(P)H:quinone oxidoreductase 1 is induced by progesterone in cardiomyocytes.
Morrissy S; Strom J; Purdom-Dickinson S; Chen QM
Cardiovasc Toxicol; 2012 Jun; 12(2):108-14. PubMed ID: 21947872
[TBL] [Abstract][Full Text] [Related]
31. The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Mol Pharmacol; 2006 Oct; 70(4):1194-203. PubMed ID: 16825487
[TBL] [Abstract][Full Text] [Related]
32. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen.
Moffit JS; Aleksunes LM; Kardas MJ; Slitt AL; Klaassen CD; Manautou JE
Toxicology; 2007 Feb; 230(2-3):197-206. PubMed ID: 17188792
[TBL] [Abstract][Full Text] [Related]
33. Dicoumarol inhibits rat NAD(P)H:quinone oxidoreductase in vitro and induces its expression in vivo.
Stiborova M; Levova K; Barta F; Dracinska H; Sulc M; Hodek P; Frei E; Arlt VM; Schmeiser HH
Neuro Endocrinol Lett; 2014; 35 Suppl 2():123-32. PubMed ID: 25638376
[TBL] [Abstract][Full Text] [Related]
34. Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1).
Yu J; Zhong B; Zhao L; Hou Y; Wang X; Chen X
Free Radic Biol Med; 2021 Sep; 173():64-69. PubMed ID: 34252539
[TBL] [Abstract][Full Text] [Related]
35. NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells.
Siegel D; Kepa JK; Ross D
PLoS One; 2012; 7(9):e44861. PubMed ID: 22984577
[TBL] [Abstract][Full Text] [Related]
36. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo.
Kapinya KJ; Harms U; Harms C; Blei K; Katchanov J; Dirnagl U; Hörtnagl H
J Neurochem; 2003 Mar; 84(5):1028-39. PubMed ID: 12603827
[TBL] [Abstract][Full Text] [Related]
37. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
38. Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1).
Lienhart WD; Strandback E; Gudipati V; Koch K; Binter A; Uhl MK; Rantasa DM; Bourgeois B; Madl T; Zangger K; Gruber K; Macheroux P
FEBS J; 2017 Apr; 284(8):1233-1245. PubMed ID: 28236663
[TBL] [Abstract][Full Text] [Related]
39. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells.
De Haan LH; Boerboom AM; Rietjens IM; van Capelle D; De Ruijter AJ; Jaiswal AK; Aarts JM
Biochem Pharmacol; 2002 Dec; 64(11):1597-603. PubMed ID: 12429349
[TBL] [Abstract][Full Text] [Related]
40. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.
Li R; Bianchet MA; Talalay P; Amzel LM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8846-50. PubMed ID: 7568029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
